Conference Proceedings

Long-term outcomes from the randomized phase II study of nivolumab (nivo) or nivo plus ipilimumab (ipi) in patients (pts) with melanoma brain metastases (mets): Anti-PD1 brain collaboration (ABC)

GV Long, VG Atkinson, S Lo, SK Sandhu, M Brown, M Gonzalez, A Guminski, RA Scolyer, L Emmett, AM Menzies, GA McArthur

ANNALS OF ONCOLOGY | OXFORD UNIV PRESS | Published : 2019